Vertex Gets Expanded FDA Approval for Cystic Fibrosis Treatment

WSJ12/21 05:00

Vertex Announces US FDA Approval of ALYFTREK, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

Businesswire12/21 04:46

Vertex Announces U.S. FDA Approval for TRIKAFTA (Elexacaftor/tezacaftor/ivacaftor and Ivacaftor) to Include Additional Non-F508del TRIKAFTA-Responsive Variants

Businesswire12/21 04:35

Vertex(VERX.US)非成瘾性止痛药遭遇“安慰剂效应” 分析师称其带来挫折

智通財経12/19 21:29

Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy

Businesswire12/19 19:00

Vertex Insider Sold Shares Worth $1,060,932, According to a Recent SEC Filing

MT Newswires12/19 05:17